Cite

APA Citation

    Mulleman, D., & Balsa, A. (2018). adalimumab concentration-based tapering strategy: as good as the recommended dosage. Annals of the rheumatic diseases, 77(4), 473–475. http://access.bl.uk/ark:/81055/vdc_100135556137.0x000062
  
Back to record